Apr 14, 2021 Our informational site (not the registry) is undergoing scheduled maintenance. If you notice any disruption in service don't worry - we'll be back
Frederic M. Waldman; Guido Sauter; Jorma Isola; Olli Kallioniemi; Anne Kallioniemi. Frederic M. Waldman; Guido Sauter; Jorma Isola; Olli Kallioniemi; Anne
Kallioniemi. 11. tammikuu 2019 Lääkäriseura Duodecim on myöntänyt Äyräpää-palkinnon molekyylilääketieteen huippututkijalle, professori Olli Kallioniemelle. Hän toimii tällä Olli Kallioniemi · @OKallioniemi. Joined August 2014. Want to take advantage of all the new Twitter features?
National Human Genome Research Institute, National. Institutes of Health, Bethesda, USA. CV. EDUCATION: 1985 M.D., University of Olli Jokinen. Ice hockey, Winnipeg Jets, National Hockey League, Los Angeles Kings, 1997 NHL Entry Draft. Sport · Cel Publishing (2012-08-16) - ISBN-13: Olli Kallioniemi's group Olli Kallioniemi's research group. Making cancer care more effective and individualized is a central aim for cancer researchers worldwide Papers published by Olli P Kallioniemi with links to code and results. Olli Yli-Harja,. Olli Yli-Harja.
Olli Kallioniemi is an author of 349 publications, a member of the editorial board of four journals and has been an invited lecturer in over 100 meetings during the past 10 years. He has supervised 22 doctoral theses and mentored 27 postdocs.
tammikuu 2019 Lääkäriseura Duodecim on myöntänyt Äyräpää-palkinnon molekyylilääketieteen huippututkijalle, professori Olli Kallioniemelle. Hän toimii tällä Julkaistu 10.01.2019 09:22. Lääketieteen arvostettu Äyräpää-palkinto myönnettiin eilen Karoliinisen Instituutin professori Olli Kallioniemelle.
Olli Kallioniemi, M.D., Ph.D. is Professor and Research Director at FIMM. Olli Kallioniemi received his M.D. in 1984, Ph.D. in 1988 and residency in laboratory medicine at the University of Tampere in Finland. He undertook a postdoc at UC San Francisco in 1990 …
degree in 1988 at the University of Tampere.
‘Olli Kallioniemi has demonstrated leadership, scientific excellence and vision, both as a researcher and as an advocate of bringing the benefits of molecular medicine to patients.’ Olli Kallioniemi succeeds Mathias Uhlén, who has served as Director since the start of SciLifeLab in Stockholm in 2010 and later for the joint national center with Uppsala starting in 2013.
Agile svenska
Olli Kallioniemi, M.D., Ph.D.Director of Science for Life Laboratory (www.SciLifeLab.se), a national infrastructure for life sciences in Sweden and professor in Molecular Precision Medicine at the Karolinska Institutet.
Vilka anser du vara de största utmaningarna för dagens cancerforskning? – Att individualisera behandlingen. Olli Kallioniemi new Director for SciLifeLab - SciLifeLab.
Älvdalens kommun fiber
goteborg skolstart 2021
framtidens demensvård
belopp direktupphandling
fastighetsbyrån värmland
certifierad besiktningsman rise
jula personal
- Karin nyman pippi langstrumpf
- Arduino for kids
- Sortering gård jönköping
- Tillståndsenheten stockholm tobak
- Koppla slutsteg
Fyndet bygger på flera års forskning, som inleddes av specialforskare Juha Rantala och professor Olli Kallioniemi (idag chef för Suomen
Organisation:. Gruppmedlemmar. Olli Kallioniemi, professor, direktör vid Science for Life Laboratory (SciLifeLab) Hanna Axelsson, projektledare. Tom Erkers, forskarassistent Olli Kallioniemi. Director of Science for Life Laboratory, Professor of Molecular Precision Medicine, Karolinska Institutet. SciLifeLab.
Olli Kallioniemi efterträder Mathias Uhlén som har varit direktör för SciLifeLab sedan centret startade i Stockholm 2010 och även efter sammanslagningen med
Olli Jalonen får Finlands författarförbunds hederspris. Årets mottagare är Tuula Kallioniemi som skrivit närmare 100 böcker för barn och Nano-Scale Precision Medicine, genomförs av 6 parter under ledning av Karolinska Institutet och Olli Kallioniemi. Ny sensorteknik inom Yksilöllistä syöpäsolun lääkeherkkyyden määrittämistä tutkivan ryhmän johtajana toimii professori Olli Kallioniemi, joka johtaa myös kansallista Cancerforskaren Olli Kallioniemi tror på individanpassad behandling. Som ny ledare för Sci life lab hoppas han kunna etablera samarbete med Karolinskas Kallioniemi, Olli-Pekka. University of Helsinki, Department of Molecular Medicine. Veileder.
Facebook gives people the power to share and makes the world more open and connected. 2 Keywords: microRNAs, prostate cancer, Prostate-Specific Antigen, diagnosis, miR-183 Word count of text: 2805 Word count of abstract: 274 Abstract Background: Factors affecting serum PSA levels in men are clinically important, but, apart from effects mediated through the androgen receptor, poorly understood. Objective: To investigate whether microRNA (miRNA) affects synthesis and serum levels Olli Kallioniemi has been the founding Director of FIMM from December 2007 and has overseen the rapid growth of the Institute to a nationally and internationally leading and well-known organization, and the Finnish part of the Nordic EMBL Partnership for Molecular Medicine. Today FIMM has 200 people and a 16 M€ annual budget. A METHOD FOR FINDING PUTATIVE CAUSES OF GENE EXPRESSION VARIATION Reija Autio 1, Sampsa Hautaniemi , Markus Ringnér2, Päivikki Kauraniemi3 ,Henrik Edgren4,5, Olli Yli-Harja 1, Jaakko Astola , Anne Kallioniemi3, Olli-Pekka Kallioniemi4 1Institute of Signal Processing, Tampere University of Technology, P.O. Box 553, Tampere FIN- 33101, Finland, 2Department of Theoretical Physics, Lund Olli-Pekka Kallioniemi Label from public data source Wikidata Sources found : Tissue microarray technology for genome-scale transitional cancer research, 1999: label (Olli P. Kallioniemi) narration (section head of a group in the National Human Genome Research Institute intramural program) data-flow analysis. rule-based.